516 related articles for article (PubMed ID: 31348505)
1. Artificial Intelligence Algorithms to Assess Hormonal Status From Tissue Microarrays in Patients With Breast Cancer.
Shamai G; Binenbaum Y; Slossberg R; Duek I; Gil Z; Kimmel R
JAMA Netw Open; 2019 Jul; 2(7):e197700. PubMed ID: 31348505
[TBL] [Abstract][Full Text] [Related]
2. Augmented interpretation of HER2, ER, and PR in breast cancer by artificial intelligence analyzer: enhancing interobserver agreement through a reader study of 201 cases.
Jung M; Song SG; Cho SI; Shin S; Lee T; Jung W; Lee H; Park J; Song S; Park G; Song H; Park S; Lee J; Kang M; Park J; Pereira S; Yoo D; Chung K; Ali SM; Kim SW
Breast Cancer Res; 2024 Feb; 26(1):31. PubMed ID: 38395930
[TBL] [Abstract][Full Text] [Related]
3. Continuous measurement of breast tumour hormone receptor expression: a comparison of two computational pathology platforms.
Ahern TP; Beck AH; Rosner BA; Glass B; Frieling G; Collins LC; Tamimi RM
J Clin Pathol; 2017 May; 70(5):428-434. PubMed ID: 27729430
[TBL] [Abstract][Full Text] [Related]
4. Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.
Snell CE; Gough M; Middleton K; Hsieh M; Furnas L; Seidl B; Gibbons K; Pyke C; Shannon C; Woodward N; Armes JE
J Clin Pathol; 2017 Nov; 70(11):954-960. PubMed ID: 28416639
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Outcomes of Immunohistochemically Defined Subtypes of Breast Cancer Less Than or Equal to 2 cm After Breast-Conserving Surgery.
Pata G; Guaineri A; Bianchi A; Amoroso V; Pasinetti N; Pasini M
J Surg Res; 2019 Apr; 236():288-299. PubMed ID: 30694768
[TBL] [Abstract][Full Text] [Related]
6. Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer.
Rexhepaj E; Brennan DJ; Holloway P; Kay EW; McCann AH; Landberg G; Duffy MJ; Jirstrom K; Gallagher WM
Breast Cancer Res; 2008; 10(5):R89. PubMed ID: 18947395
[TBL] [Abstract][Full Text] [Related]
7. AutoIHC-Analyzer: computer-assisted microscopy for automated membrane extraction/scoring in HER2 molecular markers.
Tewary S; Arun I; Ahmed R; Chatterjee S; Mukhopadhyay S
J Microsc; 2021 Jan; 281(1):87-96. PubMed ID: 32803890
[TBL] [Abstract][Full Text] [Related]
8. Comparison of central laboratory assessments of ER, PR, HER2, and Ki67 by IHC/FISH and the corresponding mRNAs (ESR1, PGR, ERBB2, and MKi67) by RT-qPCR on an automated, broadly deployed diagnostic platform.
Wu NC; Wong W; Ho KE; Chu VC; Rizo A; Davenport S; Kelly D; Makar R; Jassem J; Duchnowska R; Biernat W; Radecka B; Fujita T; Klein JL; Stonecypher M; Ohta S; Juhl H; Weidler JM; Bates M; Press MF
Breast Cancer Res Treat; 2018 Nov; 172(2):327-338. PubMed ID: 30120700
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of computer-aided diagnosis (CADx) of breast pathology using immunohistochemistry results of core needle biopsy samples for synaptophysin, oestrogen receptor and CK14/p63 for classification of epithelial proliferative lesions of the breast.
Maeda I; Kubota M; Ohta J; Shinno K; Tajima S; Ariizumi Y; Doi M; Oana Y; Kanemaki Y; Tsugawa K; Ueno T; Takagi M
J Clin Pathol; 2017 Dec; 70(12):1057-1062. PubMed ID: 28630050
[TBL] [Abstract][Full Text] [Related]
10. Cytokeratin-Supervised Deep Learning for Automatic Recognition of Epithelial Cells in Breast Cancers Stained for ER, PR, and Ki-67.
Valkonen M; Isola J; Ylinen O; Muhonen V; Saxlin A; Tolonen T; Nykter M; Ruusuvuori P
IEEE Trans Med Imaging; 2020 Feb; 39(2):534-542. PubMed ID: 31398111
[TBL] [Abstract][Full Text] [Related]
11. Current issues in ER and HER2 testing by IHC in breast cancer.
Gown AM
Mod Pathol; 2008 May; 21 Suppl 2():S8-S15. PubMed ID: 18437174
[TBL] [Abstract][Full Text] [Related]
12. Deep learned tissue "fingerprints" classify breast cancers by ER/PR/Her2 status from H&E images.
Rawat RR; Ortega I; Roy P; Sha F; Shibata D; Ruderman D; Agus DB
Sci Rep; 2020 Apr; 10(1):7275. PubMed ID: 32350370
[TBL] [Abstract][Full Text] [Related]
13. External quality assessment (EQA) program for the immunohistochemical detection of ER, PR and Ki-67 in breast cancer: results of an interlaboratory reproducibility ring study in China.
Pu T; Shui R; Shi J; Liang Z; Yang W; Bu H; Li Q; Zhang Z;
BMC Cancer; 2019 Oct; 19(1):978. PubMed ID: 31640622
[TBL] [Abstract][Full Text] [Related]
14. HER2 challenge contest: a detailed assessment of automated HER2 scoring algorithms in whole slide images of breast cancer tissues.
Qaiser T; Mukherjee A; Reddy Pb C; Munugoti SD; Tallam V; Pitkäaho T; Lehtimäki T; Naughton T; Berseth M; Pedraza A; Mukundan R; Smith M; Bhalerao A; Rodner E; Simon M; Denzler J; Huang CH; Bueno G; Snead D; Ellis IO; Ilyas M; Rajpoot N
Histopathology; 2018 Jan; 72(2):227-238. PubMed ID: 28771788
[TBL] [Abstract][Full Text] [Related]
15. Comparing breast biomarker status between routine immunohistochemistry and FISH studies and Oncotype DX testing, a study of 610 cases.
Neely C; You S; Mendoza PM; Aneja R; Sahin AA; Li X
Breast J; 2018 Nov; 24(6):889-893. PubMed ID: 30230095
[TBL] [Abstract][Full Text] [Related]
16. Dual-energy CT quantitative parameters for evaluating Immunohistochemical biomarkers of invasive breast cancer.
Wang X; Liu D; Zeng X; Jiang S; Li L; Yu T; Zhang J
Cancer Imaging; 2021 Jan; 21(1):4. PubMed ID: 33413654
[TBL] [Abstract][Full Text] [Related]
17. Effects of tissue decalcification on the quantification of breast cancer biomarkers by digital image analysis.
Gertych A; Mohan S; Maclary S; Mohanty S; Wawrowsky K; Mirocha J; Balzer B; Knudsen BS
Diagn Pathol; 2014 Nov; 9():213. PubMed ID: 25421113
[TBL] [Abstract][Full Text] [Related]
18. Brief fixation enables same-day breast cancer diagnosis with reliable assessment of hormone receptors, E-cadherin and HER2/Neu.
Halilovic A; Bulte J; Jacobs Y; Braam H; van Cleef P; Schlooz-Vries M; Werner A; Boelens O; Nagtegaal I; de Wilt H; Bult P
J Clin Pathol; 2017 Sep; 70(9):781-786. PubMed ID: 28325747
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer biomarkers before and after neoadjuvant chemotherapy: does repeat testing impact therapeutic management?
Xian Z; Quinones AK; Tozbikian G; Zynger DL
Hum Pathol; 2017 Apr; 62():215-221. PubMed ID: 28041972
[TBL] [Abstract][Full Text] [Related]
20. Digital validation of breast biomarkers (ER, PR, AR, and HER2) in cytology specimens using three different scanners.
Salama AM; Hanna MG; Giri D; Kezlarian B; Jean MH; Lin O; Vallejo C; Brogi E; Edelweiss M
Mod Pathol; 2022 Jan; 35(1):52-59. PubMed ID: 34518629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
